Machine Learning News and Research

RSS

Lung cancer prediction using biomarkers based on bronchoalveolar fluid microbiomes

The lung microbiomes of patients with benign and malignant pulmonary diseases.

23 Jan 2024

Study identifies genetic variants that influence response to preterm birth treatment

A UC San Francisco-led study has for the first time identified genetic variants that predict whether patients will respond to treatment for preterm birth, a condition that affects one in 10 infants born in the United States.

22 Jan 2024

Low-frequency ultrasound influences blood parameters, reserach shows

Research conducted by a team of scientists from Kaunas University, Lithuania, revealed that low-frequency ultrasound influences blood parameters.

22 Jan 2024

Updated pediatric sepsis definition could save countless children's lives

An international research team led by Tell Bennett, MD, MS, professor of biomedical informatics and pediatric critical care at the University of Colorado School of Medicine, released new diagnostic criteria for sepsis in children this week, marking the first update to the pediatric sepsis definition in nearly two decades.

22 Jan 2024

AI scores breakthrough in anemia treatment with novel PHD inhibitor

Clinical stage generative artificial intelligence (AI)-driven biotechnology company InSilico Medicine ("InSilico"), today announced that the Journal of Medicinal Chemistry, an ACS Publications journal focusing on critical studies about molecular structure and biological activity, has published the company's discovery of a novel PHD inhibitor for the treatment of anemia.

19 Jan 2024

Insilico Medicine leverages AI to identify promising new target for breast and gynecological cancers

Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven drug discovery company, recently published an early research that it has identified MYT1 as a promising new therapeutic target for breast and gynecological cancer, and discovered a series of novel, potent, and highly selective inhibitors specifically targeting MYT1.

19 Jan 2024

Machine learning algorithm decodes mutations driving cancer treatment resistance

In a groundbreaking study published on January 18, 2024, in Cancer Discovery, scientists at University of California San Diego School of Medicine leveraged a machine learning algorithm to tackle one of the biggest challenges facing cancer researchers: predicting when cancer will resist chemotherapy.

18 Jan 2024

AI-driven algorithm accurately predicts death, complications after percutaneous coronary intervention

When a person has one or more blocked arteries, providers may choose to conduct a minimally invasive procedure known as percutaneous coronary intervention, or PCI.

17 Jan 2024

AI shows the same accuracy as a cardiologist in detecting rheumatic heart disease

Artificial intelligence (AI) has the potential to detect rheumatic heart disease (RHD) with the same accuracy as a cardiologist, according to new research demonstrating how sophisticated deep learning technology can be applied to this disease of inequity.

16 Jan 2024

Research projects aim to develop breakthrough digital technology for improving heart and brain health

A special issue of the Journal of the American Heart Association spotlights the progress of ongoing projects aimed at developing breakthrough digital technology solutions to improve heart and brain health on a global scale.

16 Jan 2024

Is AI the future of personalized hypertension risk assessment, diagnosis, and treatment?

Artificial intelligence (AI) applications for treating hypertension (HTN) and its comorbidities.

16 Jan 2024

Pioneering Genomic Progress: An Interview with Rami Mehio, Illumina's Software and Informatics Expert

In this interview, Rami Mehio, head of software and informatics at Illumina, shares his experiences and contributions to major genomic projects like the UK Biobank's whole genome sequencing. He discusses the challenges and innovations in genomic data analysis, highlighting Illumina's role in advancing genetic research and precision medicine.

From Illumina, Inc. 15 Jan 2024

Machine Learning News and Research

Lung cancer prediction using biomarkers based on bronchoalveolar fluid microbiomes

Study identifies genetic variants that influence response to preterm birth treatment

Low-frequency ultrasound influences blood parameters, reserach shows

Updated pediatric sepsis definition could save countless children's lives

AI scores breakthrough in anemia treatment with novel PHD inhibitor

Insilico Medicine leverages AI to identify promising new target for breast and gynecological cancers

Machine learning algorithm decodes mutations driving cancer treatment resistance

AI-driven algorithm accurately predicts death, complications after percutaneous coronary intervention

AI shows the same accuracy as a cardiologist in detecting rheumatic heart disease

Research projects aim to develop breakthrough digital technology for improving heart and brain health

Is AI the future of personalized hypertension risk assessment, diagnosis, and treatment?

Pioneering Genomic Progress: An Interview with Rami Mehio, Illumina's Software and Informatics Expert

Largest study using machine learning in neuroimaging sets new benchmark for major depression diagnosis

Revolutionary AI tool forecasts kidney injury signs with high accuracy in intensive care

New analysis of cancer cells identifies 370 targets for smarter, personalized treatments

Glioblastoma tumor cells mimic neurons to evade treatment

UC San Diego develops revolutionary neural implant for deep brain recordings

Phylogenomic analysis to generate early warning signs for COVID-19 waves

Is managing emotions more effective than boosting wellbeing in curbing teens' sweet tooth?

Unearthing individual-level mutation risk patterns

AI In Healthcare eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC